Li jie Ma

Dr. Li jie Ma

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2026 in The American Journal of Surgery
Verified
Journal Article
Closed access
PFPeidang Fan
Peidang Fan
JZJiulong Zhang
Jiulong Zhang
JWJiongyuan Wang
Jiongyuan Wang
WLWeiqi Lu
Weiqi Lu
LMLi jie Ma
Li jie Ma
HTHanxing Tong
Hanxing Tong

15 December 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LMLi jie Ma
Li jie Ma
QXQiang Xia
Qiang Xia
MSMeng Sha
Meng Sha
Background/Objectives: Intrahepatic cholangiocarcinoma (ICC) and combined hepatocellular-cholangiocarcinoma (CHC) have historically been considered a contraindication for liver transplantation (LT) due to poor prognosis. However, incidental ICC/CHC has been reported in small amounts of patients undergoing LT. Methods: A retrospective cohort study was conducted to analyze patients undergoing LT with incidental ICC/CHC at our center between January 2010 and December 2021. Results: 28 patients including 12 incidental ICCs and 16 CHCs on explant were identified. Median follow-up after LT was 63 months and 13 patients died due to tumor recurrence. The 1-, 3-, and 5-year survival rates for the whole group were 85.7%, 64.3%, and 53.3%, respectively. There was no significant difference in survival rates between the ICC and CHC groups. RFS and OS in the group with tumors less than 3 cm at 1, 3, and 5 years were 85.7%, 78.6%, and 70.7% and 92.9%, 78.6%, and 64.3%, respectively, which were significantly higher than those with tumors over 3 cm (p = 0.029 and 0.089, respectively). Additionally, patients within the Milan criteria also had a superior RFS (p = 0.032) and OS trend (p = 0.097) when compared with those beyond the Milan criteria. Conclusions: These results suggest that LT could be an option for highly selected patients with an early stage of ICC/CHC.

1 January 2026 in Theranostics
Verified
Journal Article
Open access
PTPing Tao
Ping Tao
JWJiongyuan Wang
Jiongyuan Wang
PFPeidang Fan
Peidang Fan
WLWenshuai Liu
Wenshuai Liu
WLWeiqi Lu
Weiqi Lu
YZYong Zhang
Yong Zhang
Rationale: Tertiary lymphoid structures (TLSs) play a key role in the adaptive immune response within the local tumor immune microenvironment (TIME) and can predict the clinical outcome of several solid tumors. However, the clinical relevance of TLSs and their formation mechanism in gastrointestinal stromal tumors (GISTs) remain unclear. Methods: Integration analysis was performed on a single-cell RNA sequencing (scRNA-seq) cohort (n = 8), a public transcriptome cohort (n = 65), a public scRNA-seq cohort (n = 7), a tissue cohort (n = 197) and a serum cohort (n = 169) to decode the characteristics of the immunological microenvironment of GIST. The multiplex immunohistochemistry (mIHC) staining, in vitro cell culture, chemotaxis assays and antibody-dependent cellular phagocytosis (ADCP) experiments were used to validate the results of the bioinformatics analysis. Results: Preoperative imatinib targeted therapy significantly enhanced TLS formation in GIST tissues, predicting improved therapeutic efficacy and favorable prognosis. Mechanistically, imatinib remodeled the local microenvironment via tumour-associated macrophages, recruiting B cells via the CXCR4-CXCL12 axis to drive TLS development. Functionally, TLS dominated germinal centre (GC) B-cell differentiation and the formation of IgG + plasma cells (PCs), which preferentially enhanced the adaptive immune response through the ADCP effect. From a clinical perspective, we identified three distinct GIST immune classes (GICs A-C). GIC-A tumors featured abundant CD20 + B cells and TLS, as well as a favorable prognosis. They were accompanied by enhanced antigen presentation, accumulation of IgG + PCs, increased immunosuppressive properties and a high frequency of KIT exon 11 mutations. These mutations potentially serve as a predictive biomarker for future targeted and immunotherapies. Furthermore, patients with high serum IgG levels experienced significant therapeutic benefits. Conclusions: Our data show that local adaptive immunity dominated by TLS is a key factor in the efficacy of targeted therapy, and suggest that inducing IgG could be a feasible strategy for improving the prognosis of patients with GIST.

13 August 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
NZNenglin Zhang
Nenglin Zhang
QJQiuyu Jiang
Qiuyu Jiang
QMQian Ma
Qian Ma
HHHaisheng Huang
Haisheng Huang
LMLi jie Ma
Li jie Ma
SZShuping Zhou
Shuping Zhou
Background: Tertiary lymphoid structures (TLSs) are key immune niches involved in antitumor immunity. However, their functional impact depends on spatial localization, maturation status, and cellular composition within the tumor immune microenvironment (TIME). Despite the recognized role of Helicobacter pylori ( H. pylori ) in gastric carcinogenesis and immune modulation, its influence on TLS architecture and function in gastric cancer remains poorly understood. Methods: We integrated public single-cell RNA sequencing (scRNA-seq; HRA000704, GSE150290, and GSE249874; n=36), spatial transcriptomics (ST; GSE251950; n=9), and multiplex immunofluorescence (mIF) staining (n=90) to comprehensively profile TLSs across H. pylori strata. Subsequently, Kaplan–Meier (KM) analysis, restricted cubic spline (RCS) analysis, receiver operating characteristic (ROC) analysis, and concordance index (C-index) assessment were employed to determine the predictive value of distinct TLS-related features on clinical outcomes. Results: H. pylori -positive GC showed preferential peritumoral TLS localization and reduced TLS maturation. Within TLSs, H. pylori -positive tumors showed accumulation of HSP70 + B cells and reduced representation of ZNF683 + CD8 + T cells. This compositional shift was associated with disrupted CD21 + follicular dendritic cell (FDC) networks and CD23 + germinal center-like structures. Based on these reciprocal intra-TLS immune patterns, two TLS compositional states were defined. TLS type 1, marked by HSP70 + B-cell enrichment and ZNF683 + CD8 + T-cell reduction, was enriched in H. pylori -positive tumors, whereas TLS type 2 showed the opposite pattern and was associated with favorable overall survival (OS). Incorporating TLS composition into the conventional clinicopathological model increased the 5-year area under the ROC curve (AUC) from 0.847 to 0.910. Conclusions: Our study identifies an H. pylori -associated TLS compositional state characterized by HSP70 + B-cell enrichment and reduced ZNF683 + CD8 + T-cell representation. Incorporating TLS composition into clinicopathological models provided incremental prognostic information in gastric cancer.

17 October 2025 in Liver Transplantation
Verified
Journal Article
Open access
SGShiming Gong
Shiming Gong
LMLi jie Ma
Li jie Ma
BWBingran Wang
Bingran Wang
SZSui Zhou
Sui Zhou
QXQiang Xia
Qiang Xia
MFMingxuan Feng
Mingxuan Feng
The objective of this study was to assess the safety and feasibility of duct-to-duct anastomosis (DDA) in pediatric liver transplantation with left-sided grafts. The Roux-en-Y hepaticojejunostomy (HJ) represents the gold standard for biliary reconstruction in pediatric liver transplantation. Nevertheless, the feasibility of DDA in pediatric liver transplantation remains a topic of contention and is a relatively limited technique. A total of 3307 pediatric recipients who underwent LT at Renji Hospital between October 2006 and October 2023 were enrolled in the study. Of these, 218 underwent DDA with high hilar dissection and patch anastomosis, in accordance with a prospective protocol. A comprehensive analysis was conducted to determine the risk factors for exclusion from DDA and the outcomes of recipients of DDA. The mean operative time was significantly shorter in the DDA group (DDA vs. HJ=6.5 h vs. 7.0 h, p 0.99). The graft survival rates at 1 and 3 years after DDA were 98.2% and 96.8%, respectively. However, patients with Langerhans cell histiocytosis may be unsuitable candidates for DDA due to their elevated rates of DDA exclusion and biliary complications. Appropriate learning and decision-making processes ensure the safety and feasibility of DDA, with excellent perioperative and long-term outcomes. It is therefore recommended that DDA should be considered the first choice for biliary reconstruction in eligible pediatric patients of transplant.